首页> 外国专利> REMEDY COMPOSITION FOR ANTI-HYPERTENSION AND ANTI-CONGESTIVE HEART FAILURE

REMEDY COMPOSITION FOR ANTI-HYPERTENSION AND ANTI-CONGESTIVE HEART FAILURE

机译:抗高血压和抗充血性心力衰竭的药物组成

摘要

PURPOSE: To obtain a medicine composition useful for hypertension, comprising a potassium channel activator and an inhibitor of angiotensin converting enzyme. CONSTITUTION: This composition comprises (A) a compound of the formula [V is a CR1 (R1 is H, a halogen, thienyl, etc.); T is a CR2 (R2 is H, a halogen, a 1-4C alkoxy, hydroxy, etc.); W is HC or V is N, T is a CR2 and W is CH; or V and W are each N and T is CH, etc.; R3 and R4 are each H, a 1-4C alkyl or bonded to form (CH2 )n ((n) is 2-5); R5 is H or OR8 (R8 is H, a 1-4C alkyl, formyl, etc.); R9 and R10 are each H, methyl or bonded to form oxo or thio; (m) is 1-3; X is NR11 (R11 is H, an alkyl, acetyl, etc.); Y is CH, a C-halogen, N, etc.; Z is CH2 O, S, etc.], its N-oxide, its acid addition salt or quaternary ammonium salt and (B) an inhibitor of angiotensin converting enzyme in the weight ratio of the components A:B of 1:5 to 1:20, preferably 1:10 to 1:15.
机译:目的:获得用于高血压的药物组合物,其包含钾通道激活剂和血管紧张素转化酶的抑制剂。组成:该组合物包含(A)式[V为CR1(R1为H,卤素,噻吩基等)的化合物; T为CR 2(R 2为H,卤素,1-4C烷氧基,羟基等); W为HC或V为N,T为CR2且W为CH; V和W分别为N,T为CH等;或R3和R4各自为H,1-4C烷基或键合形成(CH2)n((n)为2-5); R5为H或OR8(R8为H,1-4C烷基,甲酰基等); R9和R10各自为氢,甲基或键合形成氧代或硫代; (m)是1-3; X为NR11(R11为H,烷基,乙酰基等); Y为CH,C-卤素,N等; Z为CH2 O,S等],其N氧化物,其酸加成盐或季铵盐,以及(B)组分A:B的重量比为1:5至1的血管紧张素转化酶抑制剂:20,最好是1:10至1:15。

著录项

  • 公开/公告号JPH0344321A

    专利类型

  • 公开/公告日1991-02-26

    原文格式PDF

  • 申请/专利权人 SANDOZ AG;

    申请/专利号JP19900177203

  • 发明设计人 ROBERUTO PAURU HOFU;URURITSUHI KUBUASUTO;

    申请日1990-07-03

  • 分类号A61K31/35;A61K31/38;A61K31/40;A61K31/435;A61P9/00;A61P9/12;

  • 国家 JP

  • 入库时间 2022-08-22 06:00:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号